Biomarker‐adapted treatment in high‐risk large B‐cell lymphoma
- DOI
- 10.1002/hem3.70139
- Published
- 2025-05
- Container
- HemaSphere
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/hem3.70139,
title = {Biomarker‐adapted treatment in high‐risk large B‐cell lymphoma},
author = {Sirpa Leppä and Leo Meriranta and Maare Arffman and Judit Jørgensen and Marja‐Liisa Karjalainen‐Lindsberg and Klaus Beiske and Mette Pedersen and Kristina Drott and Annika Pasanen and Kristiina Karihtala and Susanna Mannisto and Bente Wold and Marianne Brodtkorb and Unn‐Merete Fagerli and Thomas Stauffer Larsen and Lars Munksgaard and Kaisa Sunela and Øystein Fluge and Sirkku Jyrkkiö and Peter Brown and Harald Holte},
year = {2025},
journal = {HemaSphere},
doi = {10.1002/hem3.70139},
url = {https://doi.org/10.1002/hem3.70139}
}RIS
TY - JOUR TI - Biomarker‐adapted treatment in high‐risk large B‐cell lymphoma AU - Sirpa Leppä AU - Leo Meriranta AU - Maare Arffman AU - Judit Jørgensen AU - Marja‐Liisa Karjalainen‐Lindsberg AU - Klaus Beiske AU - Mette Pedersen AU - Kristina Drott AU - Annika Pasanen AU - Kristiina Karihtala AU - Susanna Mannisto AU - Bente Wold AU - Marianne Brodtkorb AU - Unn‐Merete Fagerli AU - Thomas Stauffer Larsen AU - Lars Munksgaard AU - Kaisa Sunela AU - Øystein Fluge AU - Sirkku Jyrkkiö AU - Peter Brown AU - Harald Holte PY - 2025 JO - HemaSphere DO - 10.1002/hem3.70139 UR - https://doi.org/10.1002/hem3.70139 ER -
APA
Leppä, S., Meriranta, L., Arffman, M., Jørgensen, J., Karjalainen‐Lindsberg, M., Beiske, K., Pedersen, M., Drott, K., Pasanen, A., Karihtala, K., Mannisto, S., Wold, B., Brodtkorb, M., Fagerli, U., Larsen, T. S., Munksgaard, L., Sunela, K., Fluge, Ø., Jyrkkiö, S., Brown, P., & Holte, H. (2025). Biomarker‐adapted treatment in high‐risk large B‐cell lymphoma. HemaSphere. https://doi.org/10.1002/hem3.70139
Source records
- crossref · retrieved 2026-09-27T15:49:24.429Z